Potency of antigenic and serologic tests based on CNTKCQTP linear epitope on H5N1 haemagglutinin for Avian Influenza

Simson Tarigan, . Sumarningsih

Abstract

Rapid diagnostic tools or point-of-care (POC) test is needed in the effort to control and eradicate the high pathogenic avian influenza (HPAI) H5N1 in Indonesia. Accuracy of a POC test is determined by the specificity of antibodies, which is the main component of a POC test. Recently a linear epitope, CNTCKQTP epitope, located at 274-281 amino acid residue of H5 hemagglutinin has been confirmed to be present all clade of H5N1 viruses. This study aimed at producing and evaluating the reactivity of a monospecific, polyclonal antibody against the epitope. The Antibody was produced by immunising a goat with the peptide in the form of multiple antigen peptide (MAP). The specificity of the antibody was estimated by assaying its reactivity against influenza virus subtypes H3N3, H4N4, H5N1, H6N5, H7N7, H9N2, H10N7 and H11N9; and recombinant hemagglutinins H1-H12, H14 and H15 with ELISA and immunoblot. The results of the assay showed that CNTKCQTP antibody was not specific for H5 haemagglutinin because it cross-reacted with other haemagglutinins especially H7, H8 and H9. The potential of the peptide containing the epitope, GNCNTKCQTPMGAINSS. as an ELISA reagent for assaying H5 antibodies in chickens previously vaccinated and challenged with the H5N1 virus was also evaluated in this study. In contrast, the results of previous studies, the ELISA using GNCNTKCQTPMGAINSS as coating antigen was not sensitive in detecting antibody to haemagglutinin H5 in chickens.

Key Words: AI Virus, Hemagglutinin H5, CNTKCQTP Epitope, MAP, Immunoassay

Keywords

AI Virus; Hemagglutinin H5; CNTKCQTP Epitope; MAP; Immunoassay

Full Text:

PDF

References

Bhat S, Bhatia S, Sood R, Bhatnagar H, Pateriya A, Venkatesh G. 2013. Production and characterization of monoclonal antibodies against nucleoprotein of avian influenza virus. Monoclon Antib Immunodiagn Immunother. 32:413-418.

Claas EC, de Jong JC, van Beek R, Rimmelzwaan GF, Osterhaus AD. 1998. Human influenza virus A/HongKong/156/97 (H5N1) infection. Vaccine. 16:977-978.

[FAO] Food and Agriculture Organization. 2011. Approaches to controlling, preventing and eliminating H5N1 Highly Pathogenic Avian Influenza in endemic countries. FAO Animal Production and Health Paper No. 171.

[FAO] Food and Agriculture Organization. 2012. H5N1 HPAI global overview, January–March 2012. Issue No. 31. [accessed April 16th 2015]. http://www.fao.org /docrep/015/an388e/an388e.pdf

Gavin PJ, Thomson RB. 2003. Review of rapid diagnostic tests for influenza. Clin Appl Immunol Rev. 4:151-172.

Hawkes P, Echalar R, Budiharta S, Soenarjo S. 2014. USAID/Indonesia Avian And Pandemic Influenza (API) program evaluation: 2009–2014. GH Tech Project Bridge IV, Report No. 14-B4-009.

Ho HT, Qian HL, He F, Meng T, Szyporta M, Prabhu N, Prabakaran M, Chan KP, Kwang J. 2009. Rapid detection of H5N1 subtype influenza viruses by antigen capture enzyme-linked immunosorbent assay using H5- and N1-specific monoclonal antibodies. Clin Vaccine Immunol. 16:726-732.

Khan FH. 2014. Antibodies and their applications. In: Verma AS, Singh A, editors. Animal biotechnology-model in discovery and translation. Amsterdam (NL): Acad Press. p. 473-490.

Lin J, Wang R, Jiao P, Li Y, Li Y, Liao M, Yu Y, Wang M. 2015. An impedance immunosensor based on low-cost microelectrodes and specific monoclonal antibodies for rapid detection of avian influenza virus H5N1 in chicken swabs. Biosens Bioelectron. 67:546-552.

Prabakaran M, Ho HT, Prabhu N, Velumani S, Szyporta M, He F, Chan KP, Chen LM, Matsuoka Y, Donis RO, Kwang J. 2009. Development of epitope-blocking ELISA for universal detection of antibodies to human H5N1 influenza viruses. PLoS One. 4:e4566.

Rai M, Bhatia S, Malik YP, Dubey SC. 2010. Production and characterization of monoclonal antibodies against NS1 protein of H5N1 avian influenza virus. Hybridoma (Larchmt). 29:183-186.

Rosenberg IM. 1996a. Protein analysis and purification. benchtop techniques. Boston (USA): Birkshauser Boston. p. 158-159.

Rosenberg IM. 1996b. Protein analysis and purification. benchtop techniques. Boston (USA): Birkhauser Boston. p. 130.

Sims LD, Domenech J, Benigno C, Kahn S, Kamata A, Lubroth J, Martin V, Roeder P. 2005. Origin and evolution of highly pathogenic H5N1 avian influenza in Asia. Vet Rec. 157:159-164.

Singh A, Chaudhry S, Agarwal A, Verma AS. 2014. Antibodies: Monoclonal and Polyclonal. In: Verma AS, Singh A, editors. Animal biotechnology-model in discovery and translation. Amsterdam (NL): Acad Press. p. 265-287.

Tarigan S. 2016. Peranan Point-of-Care-Test dalam pengendalian High Pathogenic Avian Influenza di Indonesia. Wartazoa. 26:39-50.

Tarigan S, Indriani R, Durr PA, Ignjatovic J. 2015. Characterization of the M2e antibody response following highly pathogenic H5N1 avian influenza virus infection and reliability of M2e ELISA for identifying infected among vaccinated chickens. Avian Pathol. 44:259-268.

Velumani S, Ho HT, He F, Musthaq S, Prabakaran M, Kwang J. 2011. A novel peptide ELISA for universal detection of antibodies to human H5N1 influenza viruses. PLoS One. 6:e20737.

Wang X, Castro AE, Castro MD, Lu H, Weinstock D, Soyster N, Scheuchenzuber W, Perdue M. 2000. Production and evaluation criteria of specific monoclonal antibodies to the hemagglutinin of the H7N2 subtype of avian influenza virus. J Vet Diagn Invest. 12:503-509.

Wei J, Yan B, Chen Z, Li T, Deng F, Wang H, Hu Z. 2011. Production and characterization of monoclonal antibodies against the hemagglutinin of H5N1 and antigenic investigation of avian influenza H5N1 viruses isolated from China. Can J Microbiol. 57:42-48.

Refbacks

  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.